ArticleScientific reports2022

The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma and COPD patients in vitro.

Javier Milara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.